| Product Code: ETC6759344 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Colombia Bacteriophages Therapy Market Overview |
3.1 Colombia Country Macro Economic Indicators |
3.2 Colombia Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Colombia Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Colombia Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Colombia Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Colombia Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Colombia Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Colombia Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Colombia Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant bacterial infections in Colombia |
4.2.2 Growing awareness and adoption of bacteriophage therapy as an alternative to antibiotics |
4.2.3 Supportive government initiatives and funding for research and development in the field of bacteriophage therapy |
4.3 Market Restraints |
4.3.1 Limited availability of bacteriophage therapy products in the Colombian market |
4.3.2 Lack of standardized regulations and guidelines for bacteriophage therapy |
4.3.3 Resistance from traditional healthcare providers and pharmaceutical companies towards adopting bacteriophage therapy |
5 Colombia Bacteriophages Therapy Market Trends |
6 Colombia Bacteriophages Therapy Market, By Types |
6.1 Colombia Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Colombia Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Colombia Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Colombia Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Colombia Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Colombia Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Colombia Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Colombia Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Colombia Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Colombia Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Colombia Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Colombia Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Colombia Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Colombia Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Colombia Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Colombia Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Colombia Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Colombia Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Colombia Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Colombia Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Colombia Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Colombia Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Colombia Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Colombia Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Colombia Bacteriophages Therapy Market Export to Major Countries |
7.2 Colombia Bacteriophages Therapy Market Imports from Major Countries |
8 Colombia Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted on bacteriophage therapy in Colombia |
8.2 Investment in research and development for bacteriophage therapy in the country |
8.3 Number of healthcare facilities offering bacteriophage therapy as a treatment option |
8.4 Patient outcomes and success rates with bacteriophage therapy |
8.5 Public awareness and perception of bacteriophage therapy in Colombia |
9 Colombia Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Colombia Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Colombia Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Colombia Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Colombia Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Colombia Bacteriophages Therapy Market - Competitive Landscape |
10.1 Colombia Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Colombia Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here